Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11771157rdf:typepubmed:Citationlld:pubmed
pubmed-article:11771157lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11771157lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:11771157lifeskim:mentionsumls-concept:C0878544lld:lifeskim
pubmed-article:11771157lifeskim:mentionsumls-concept:C0011633lld:lifeskim
pubmed-article:11771157lifeskim:mentionsumls-concept:C0036421lld:lifeskim
pubmed-article:11771157lifeskim:mentionsumls-concept:C1302234lld:lifeskim
pubmed-article:11771157lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:11771157pubmed:issue6lld:pubmed
pubmed-article:11771157pubmed:dateCreated2001-12-28lld:pubmed
pubmed-article:11771157pubmed:abstractTextWe report a 23-year-old man suffering from an overlap syndrome of systemic scleroderma and dermatomyositis who died from severe dilated cardiomyopathy. Because his weakness involved predominantly muscles in the facio-scapulo-humeral regions, he was initially thought to have facioscapulohumeral muscular dystrophy (FSHD) at other hospitals. However, he had also Raynaud phenomenon and low voltages on electrocardiogram. His apparent facial weakness was mainly due to atrophic skin changes. Unlike FSHD, the deltoid and levator scapulae muscles were also atrophic. Deltoid muscle biopsy performed one year earlier at another hospital showed mild myopathic changes without inflammation, but there were scattered thick-walled endomysial capillaries, suggesting inflammatory myopathy. Biceps brachii muscle biopsy in our hospital showed marked inflammation with perifascicular atrophy. In this patient, the cardiac muscle involvement progressed together with the skeletal muscle inflammation before scleroderma became apparent.lld:pubmed
pubmed-article:11771157pubmed:languagejpnlld:pubmed
pubmed-article:11771157pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11771157pubmed:citationSubsetIMlld:pubmed
pubmed-article:11771157pubmed:statusMEDLINElld:pubmed
pubmed-article:11771157pubmed:monthJunlld:pubmed
pubmed-article:11771157pubmed:issn0009-918Xlld:pubmed
pubmed-article:11771157pubmed:authorpubmed-author:ToyamaJJlld:pubmed
pubmed-article:11771157pubmed:authorpubmed-author:OgawaMMlld:pubmed
pubmed-article:11771157pubmed:authorpubmed-author:KawaiMMlld:pubmed
pubmed-article:11771157pubmed:authorpubmed-author:NonakaIIlld:pubmed
pubmed-article:11771157pubmed:authorpubmed-author:OyaYYlld:pubmed
pubmed-article:11771157pubmed:issnTypePrintlld:pubmed
pubmed-article:11771157pubmed:volume41lld:pubmed
pubmed-article:11771157pubmed:ownerNLMlld:pubmed
pubmed-article:11771157pubmed:authorsCompleteYlld:pubmed
pubmed-article:11771157pubmed:pagination289-95lld:pubmed
pubmed-article:11771157pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11771157pubmed:meshHeadingpubmed-meshheading:11771157...lld:pubmed
pubmed-article:11771157pubmed:meshHeadingpubmed-meshheading:11771157...lld:pubmed
pubmed-article:11771157pubmed:meshHeadingpubmed-meshheading:11771157...lld:pubmed
pubmed-article:11771157pubmed:meshHeadingpubmed-meshheading:11771157...lld:pubmed
pubmed-article:11771157pubmed:meshHeadingpubmed-meshheading:11771157...lld:pubmed
pubmed-article:11771157pubmed:meshHeadingpubmed-meshheading:11771157...lld:pubmed
pubmed-article:11771157pubmed:meshHeadingpubmed-meshheading:11771157...lld:pubmed
pubmed-article:11771157pubmed:meshHeadingpubmed-meshheading:11771157...lld:pubmed
pubmed-article:11771157pubmed:year2001lld:pubmed
pubmed-article:11771157pubmed:articleTitle[A patient with dermatomyositis and systemic sclerosis with preferential facioscapulohumeral muscle involvement and fatal cardiomyopathy].lld:pubmed
pubmed-article:11771157pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11771157pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:11771157pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:11771157pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed